Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Protagonist Therapeutics (PTGX) Return on Assets (2017 - 2025)

Historic Return on Assets for Protagonist Therapeutics (PTGX) over the last 9 years, with Q3 2025 value amounting to 0.06%.

  • Protagonist Therapeutics' Return on Assets fell 2200.0% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year decrease of 2200.0%. This contributed to the annual value of 0.5% for FY2024, which is 7600.0% up from last year.
  • Per Protagonist Therapeutics' latest filing, its Return on Assets stood at 0.06% for Q3 2025, which was down 2200.0% from 0.07% recorded in Q2 2025.
  • Protagonist Therapeutics' 5-year Return on Assets high stood at 0.41% for Q4 2024, and its period low was 0.57% during Q1 2023.
  • Its 5-year average for Return on Assets is 0.16%, with a median of 0.25% in 2021.
  • Its Return on Assets has fluctuated over the past 5 years, first surged by 9000bps in 2024, then tumbled by -2500bps in 2025.
  • Over the past 5 years, Protagonist Therapeutics' Return on Assets (Quarter) stood at 0.35% in 2021, then crashed by -38bps to 0.48% in 2022, then surged by 52bps to 0.23% in 2023, then soared by 278bps to 0.41% in 2024, then crashed by -84bps to 0.06% in 2025.
  • Its Return on Assets stands at 0.06% for Q3 2025, versus 0.07% for Q2 2025 and 0.08% for Q1 2025.